Home > Insider Trading > Filing (0001567619-18-001672)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080014	Innoviva Inc.	INVA	Pharmaceutical Preparations (2834)	943265960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1485939	B George Abercrombie	2000 Sierra Point Parkway, Suite 500 Brisbane CA 94005	Sr. Vp & Chief Comm. Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-20	5,680	$14.08	293,479	No	4	F	Direct
Common Stock	Disposition	2018-08-21	8,000	$14.11	285,479	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.9100 to $14.1950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.